CJC-1295 (No DAC) 5mg + Ipamorelin 5mg is a dual-peptide research formulation developed for laboratory investigations involving growth hormone signaling pathways, endocrine regulation, and peptide interaction studies. Combining a Growth Hormone-Releasing Hormone (GHRH) analog with a selective Growth Hormone Secretagogue (GHS), this lyophilized blend provides researchers with a convenient platform for studying complementary mechanisms involved in pulsatile growth hormone release.
Each vial contains 5mg of CJC-1295 (without Drug Affinity Complex) and 5mg of Ipamorelin, manufactured under controlled laboratory conditions and supplied as a high-purity lyophilized powder. The combination is intended exclusively for laboratory and in vitro research and is not intended for human or veterinary use.
Product Overview
CJC-1295 (No DAC) is a synthetic GHRH analog designed for research involving endogenous growth hormone signaling. Unlike the DAC version, this formulation has a shorter half-life, making it suitable for studies evaluating natural pulsatile hormone release rather than prolonged stimulation.
Ipamorelin is a selective growth hormone secretagogue that has been investigated for its ability to activate growth hormone release through ghrelin receptor pathways while demonstrating minimal activity on cortisol and prolactin compared with earlier secretagogues.
When studied together, these peptides provide researchers with an opportunity to examine two complementary signaling pathways involved in growth hormone regulation.
Research Applications
This peptide blend is commonly selected for laboratory investigations involving:
- Growth hormone signaling pathways
- GHRH and ghrelin receptor interactions
- Endocrine pathway modulation
- Cellular regeneration research
- Protein synthesis mechanisms
- Recovery and tissue remodeling pathways
- Metabolic signaling studies
- Peptide synergy research
- IGF-1 pathway investigations
- Hormonal feedback mechanisms
Current investigations remain experimental, and additional research continues to explore the biological activity of these compounds.
Why Researchers Study This Combination
Combining CJC-1295 (No DAC) with Ipamorelin allows researchers to investigate two distinct yet complementary biological mechanisms.
CJC-1295 (No DAC) acts through GHRH receptors, while Ipamorelin primarily targets growth hormone secretagogue receptors. Studying both compounds together enables laboratory models to evaluate coordinated signaling responses, hormone pulse characteristics, and downstream cellular pathways.
The shorter activity profile of the No DAC version also makes this blend useful for experiments designed to observe more physiologically timed hormone release patterns.
Product Specifications
- Product Name: CJC-1295 (No DAC) + Ipamorelin
- Contents: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin
- Total Peptide Content: 10mg
- Form: Lyophilized powder
- Purity: Laboratory-grade
- Research Classification: Experimental peptide blend
- Intended Use: Laboratory and analytical research only
Quality Standards
Every batch is produced using strict quality-control procedures to help ensure consistency between production lots.
Quality verification includes evaluation for:
- Identity confirmation
- Purity testing
- Batch consistency
- Sterility during manufacturing
- Controlled production conditions
These quality measures help support reproducible laboratory research while maintaining high manufacturing standards.
Storage Guidelines
To preserve peptide stability during research:
- Store unopened vials in a cool, dry location away from direct light.
- Refrigerate after reconstitution when applicable.
- For extended storage, freezing according to laboratory protocols may help maintain peptide integrity.
- Avoid repeated freeze-thaw cycles whenever possible.
Proper handling and storage contribute to maintaining product quality throughout research projects.
Laboratory Use Only
This product is supplied exclusively for laboratory, analytical, and scientific research.
It is not intended for:
- Human consumption
- Veterinary use
- Therapeutic applications
- Diagnostic use
- Disease prevention or treatment
Researchers should follow appropriate laboratory procedures and institutional guidelines when handling this material.
Frequently Asked Questions
What is included in this blend?
Each vial contains 5mg of CJC-1295 (No DAC) and 5mg of Ipamorelin in lyophilized powder form for laboratory research.
Why is CJC-1295 (No DAC) paired with Ipamorelin?
Researchers often study this combination because the peptides influence different signaling pathways involved in endogenous growth hormone regulation, making them useful for investigating complementary biological mechanisms.
What makes the No DAC version different?
Unlike CJC-1295 with Drug Affinity Complex (DAC), the No DAC formulation has a shorter duration of activity, making it suitable for research focused on pulsatile growth hormone signaling rather than prolonged receptor stimulation.
Is this product intended for human use?
No. This product is supplied strictly for laboratory and research purposes only. It is not intended for human or animal consumption.
